Conmed/$CNMD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Conmed

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.

Ticker

$CNMD

Primary listing

NYSE

Industry

Health Care Equipment & Supplies

Employees

3,900

ISIN

US2074101013

Conmed Metrics

BasicAdvanced
$1.6B
13.73
$3.81
1.29
$0.80
1.53%

What the Analysts think about Conmed

Analyst ratings (Buy, Hold, Sell) for Conmed stock.

Bulls say / Bears say

CONMED reported a 4.0% year-over-year increase in Q3 2024 sales, reaching $316.7 million, indicating strong operational performance. (Business Wire)
Analysts have a consensus 'Moderate Buy' rating for CONMED, with an average 12-month price target of $79.80, suggesting potential upside from current levels. (MarketBeat)
The company's Orthopedic Surgery segment saw a 4.7% increase in sales during Q3 2024, driven by demand for sports medicine and BioBrace products, highlighting growth in key product lines. (BeyondSPX)
CONMED's stock price has declined approximately 45% from its 52-week high, reflecting potential investor concerns. (GuruFocus)
The company has a relatively high debt level, with $114.6 million in borrowings on the term loan facility and $36.0 million under the revolving credit facility, which could impact financial flexibility. (DCF.fm)
Some analysts have lowered their price targets for CONMED, with Piper Sandler reducing it from $95.00 to $80.00, indicating tempered expectations. (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.

Conmed Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Conmed Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CNMD

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Jul3
Conmed
Dividend·Payment
$0.20Per share
FAQs